myfortic (mycophenolic acid) delayed-release tablets are an enteric formulation of mycophenolate sodium that delivers the active moiety mycophenolic acid (MPA). myfortic is an immunosuppressive agent.
myfortic: It's All in the Delivery >>
Read about the myfortic option, comparable efficacy after conversion to myfortic, efficacy for de novo patients, safety profile, and dosing information.
Renal Transplant Resources >>
Additional transplant links and data for healthcare professionals.
Renal Transplant Patient Handout >>
This printable brochure can help answer patient questions about the myfortic enteric coating, efficacy, side effects, and dosing.
Important myfortic Trials >>
Important trials regarding the safety and efficacy of myfortic.
Reimbursement Information >>
Download and print the Reimbursement Coder and find out about the advantages of the Reimbursement Hotline.
Click here for complete prescribing information, which includes contraindications, warnings, precautions, and adverse events.
Back to top
|
